Genfit S A Asset Turnover Ratio (GNFT), as of fourth quarter 2024, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Genfit S a   (NASDAQ: GNFT)
 

Genfit S A Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Genfit S A asset turnover ratio, the ability of Genfit S A 's assets to generate revenue in the fourth quarter 2024, increased sequentially to 0.44 in the fourth quarter (Dec 31 2024), yet the ratio remained below the average, as GNFT's position remain challenging.

Within sector 16 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2024 compared to the preceding quarter from 4 to 1609.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GNFT Asset Turnover Ratio (Dec 31 2024)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2023)
IV. Quarter
Y / Y Asset Change -14.26 % -12.91 % -12.91 % -12.91 % -11.9 %
Y / Y Revenue Change 85.82 % - - - 43.7 %
Asset Turnover Ratio (TTM) 0.44 - - - 0.21
GNFT's Total Ranking # 1609 # 4 # # #
Seq. Asset Change 25.84 % 0 % 0 % -31.86 % 27.82 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 17
Healthcare Sector # 150
Overall Market # 1609

Asset Turnover Ratio Statistics
High Average Low
12.36 5.11 0.61
(Dec 31 2021)   (Dec 31 2020)




GNFT Company Profile • Back to GNFT Efficiency Comparisons • Compare GNFT Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2024 Assets at quarter ending Dec 31 2024
Lifeloc Technologies Inc   1.02 $ 8.538  Millions$ 8.352  Millions
Tela Bio Inc   1.01 $ 68.488  Millions$ 67.907  Millions
Tandem Diabetes Care Inc   0.99 $ 939.574  Millions$ 950.984  Millions
Sonoma Pharmaceuticals Inc   0.98 $ 13.973  Millions$ 14.210  Millions
Addus Homecare Corp  0.98 $ 1,154.021  Millions$ 1,174.022  Millions
Nuo Therapeutics Inc   0.98 $ 1.365  Millions$ 1.393  Millions
Acadia Pharmaceuticals Inc   0.97 $ 957.797  Millions$ 983.457  Millions
Axogen inc   0.97 $ 187.338  Millions$ 192.790  Millions
Accuray Incorporated  0.97 $ 452.724  Millions$ 468.215  Millions
Esperion Therapeutics Inc   0.96 $ 332.314  Millions$ 345.828  Millions
Ufp Technologies Inc   0.96 $ 503.693  Millions$ 524.395  Millions
Pediatrix Medical Group Inc   0.96 $ 2,012.919  Millions$ 2,098.272  Millions
Healthlynked Corp  0.95 $ 3.008  Millions$ 3.183  Millions
Ensign Group Inc  0.94 $ 4,260.485  Millions$ 4,511.066  Millions
Cerus Corporation  0.94 $ 179.522  Millions$ 191.272  Millions
Biocryst Pharmaceuticals Inc   0.94 $ 450.712  Millions$ 480.496  Millions
Treace Medical Concepts Inc   0.93 $ 209.357  Millions$ 224.707  Millions
Cytomx Therapeutics Inc   0.92 $ 138.103  Millions$ 150.855  Millions
Ensysce Biosciences Inc   0.91 $ 5.210  Millions$ 5.713  Millions
Cadre Holdings inc   0.91 $ 566.937  Millions$ 622.351  Millions
National Healthcare Corp  0.91 $ 1,307.382  Millions$ 1,436.619  Millions
Procaps Group S a   0.91 $ 373.795  Millions$ 411.693  Millions
Angiodynamics Inc   0.91 $ 284.471  Millions$ 313.453  Millions
Strata Critical Medical Inc   0.90 $ 248.693  Millions$ 275.686  Millions
Corcept Therapeutics Inc  0.90 $ 675.040  Millions$ 748.825  Millions
Orthofix Medical Inc   0.90 $ 798.885  Millions$ 887.304  Millions
Ardelyx inc   0.90 $ 333.615  Millions$ 372.372  Millions
Ironwood Pharmaceuticals inc   0.89 $ 351.410  Millions$ 393.717  Millions
Community Health Systems Inc   0.89 $ 12,634.000  Millions$ 14,196.750  Millions
Apellis Pharmaceuticals Inc   0.89 $ 781.367  Millions$ 880.832  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.